Results 141 to 150 of about 2,937,657 (199)
The impact of the United States most favored nation policies on prices of branded medicines and research and development. [PDF]
Health Policy OpenEpstein D.
europepmc +1 more source
Nicotine analogs in e-cigarettes: unrecognized health risks and insufficient regulatory oversight. [PDF]
Toxicol SciGraham AA, Corteselli EM.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Nature Reviews Drug Discovery, 2015
This analysis provides an overview of the current pipeline of drugs for psoriasis and an outlook for the psoriasis market, which is growing substantially.
Salman, Rizvi +2 more
exaly +3 more sources
This analysis provides an overview of the current pipeline of drugs for psoriasis and an outlook for the psoriasis market, which is growing substantially.
Salman, Rizvi +2 more
exaly +3 more sources
Nature Reviews Drug Discovery, 2018
This article discusses the market for therapies for haemophila, which is forecast to change substantially with the recent launch of emicizumab and the potential future approvals of gene therapies and non-factor treatments.
Kerri, Brown, Graeme, Green
openaire +2 more sources
This article discusses the market for therapies for haemophila, which is forecast to change substantially with the recent launch of emicizumab and the potential future approvals of gene therapies and non-factor treatments.
Kerri, Brown, Graeme, Green
openaire +2 more sources
Nature Reviews Drug Discovery, 2017
Two PD-1 directed checkpoint inhibitors have recently been approved for squamous cell carcinoma of the head and neck (SCCHN). Further checkpoint inhibitors, as well as other molecularly targeted agents and cytokine-based immunotherapies, are currently in the late-stage pipeline and are poised to change the treatment paradigm for SCCHN.
Jennifer, Bamford, Rachel M, Webster
openaire +2 more sources
Two PD-1 directed checkpoint inhibitors have recently been approved for squamous cell carcinoma of the head and neck (SCCHN). Further checkpoint inhibitors, as well as other molecularly targeted agents and cytokine-based immunotherapies, are currently in the late-stage pipeline and are poised to change the treatment paradigm for SCCHN.
Jennifer, Bamford, Rachel M, Webster
openaire +2 more sources
Peptides as Drugs: Is There a Market?
Journal of Peptide Science, 2001What is the value of the ethical pharmaceutical market? What is the share of the peptides and proteins market within it? Is it worthwhile to invest in research in that field with the hope of finding new drugs? Do we, as scientists, have a future when starting our career in the isolation, synthesis or production of peptides and proteins?
openaire +2 more sources
The Lancet, 2000
A new therapy is enormously expensive: it costs up to $350 million to bring a new drug to market, or more than $500 million if failures are taken into account, most of the money going to meet the regulatory requirements for phase II and phase III clinical trials.
E A, Gale, A, Clark
openaire +2 more sources
A new therapy is enormously expensive: it costs up to $350 million to bring a new drug to market, or more than $500 million if failures are taken into account, most of the money going to meet the regulatory requirements for phase II and phase III clinical trials.
E A, Gale, A, Clark
openaire +2 more sources
International Criminal Justice Review, 2017
There is a divide between economic and criminological research on illicit drug markets. Economists have focused on modeling markets at an abstract level, while criminologists have focused on offending in individual street-level marketplaces. This article combines the economic and criminological research on illicit drug markets through the lens of ...
openaire +1 more source
There is a divide between economic and criminological research on illicit drug markets. Economists have focused on modeling markets at an abstract level, while criminologists have focused on offending in individual street-level marketplaces. This article combines the economic and criminological research on illicit drug markets through the lens of ...
openaire +1 more source
The gastroesophageal cancer drug market
Nature Reviews Drug Discovery, 2018Immune checkpoint inhibitors are forecast to expand the market for gastroesophageal cancer drugs, which is particularly large in Asia.
Paul, Wilcock, Rachel M, Webster
openaire +2 more sources
Silicon Switches of Marketed Drugs
Mini-Reviews in Medicinal Chemistry, 2006The application of organosilicon chemistry is a strategy to develop best in class drugs applied to targets that have been validated as tractable and drug-able. Silicon switches of known drugs have been synthesised and evaluated in biological assay systems then compared to their marketed all-carbon counterparts.
P K, Pooni, G A, Showell
openaire +2 more sources